IEQ Capital’s Mersana Therapeutics MRSN Stock Holding History

IEQ Capital’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,955	Closed	-$375K	–	2008
2025 Q4	$375K	Sell	12,955 -2,285	-15%	-$43.4K	﹤0.01%	1449
2025 Q3	$118K	Sell	15,240 -10,298	-40%	-$77.3K	﹤0.01%	1749
2025 Q2	$189K	Sell	25,538 -2,743	-10%	-$24.1K	﹤0.01%	1624
2025 Q1	$243K	Buy	+28,281	New	+$436K	﹤0.01%	1278

Other funds holding MRSN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

IEQ Capital's MRSN Position: Q1 2026 in Review

IEQ Capital sold out of Mersana Therapeutics (MRSN) in Q1 2026, closing a stake of 12,955 shares — an estimated $375K sold.

IEQ Capital first reported a position in MRSN in Q1 2025 and held it in 4 quarters. The position peaked at $375K in Q4 2025. 1 fund tracked by Wall St. Rank holds MRSN as of Q1 2026.

IEQ Capital reported no remaining Mersana Therapeutics position as of Q1 2026 after selling out during the quarter.
IEQ Capital sold 12,955 Mersana Therapeutics shares in Q1 2026, an estimated $375K.
IEQ Capital first reported a position in Mersana Therapeutics in Q1 2025 and held it in 4 quarters.
IEQ Capital's Mersana Therapeutics position peaked at $375K in Q4 2025.
1 fund tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.